1.. INTRODUCTION {#S1}
================

Porcine contagious pleuropneumonia is caused by the Gram-negative rod *Actinobacillus pleuropneumoniae.* This disease, which has been described world-wide, affects swine of all ages and has a serious impact on economy, ecology and animal welfare in the pig rearing industry \[[@R57]\]. Characterized by fibrinohemorrhagic necrotizing bronchopneumonia and fibrinous pleuritis, it often takes a fatal course. In vitro growth of *A. pleuropneumoniae* may be NAD dependent (biotype 1 strains) or NAD independent (biotype 2 strains) \[[@R87]\]. On the basis of the antigenic properties of the capsular polysaccharides and the cell wall lipopolysaccharides, *A. pleuropneumoniae* has been divided into 15 serotypes \[[@R17]\]. Although all serotypes can cause disease, differences in virulence exist \[[@R60]\]. In most herds, one serotype predominates, although several different serotypes have been demonstrated on one and the same farm \[[@R31]\]. Herds with a high traffic of animals have a higher risk of becoming infected with new serotypes.

Outbreaks of acute pleuropneumonia may occur in all age groups, but are mainly observed in fatteners. Animals of 12 weeks of age seem to be most susceptible \[[@R35]\]. In endemically infected herds, *A. pleuropneumoniae* may be detected in tonsillar samples taken from piglets less than 4 weeks of age, whereas its presence in lung tissue and the induction of lung lesions is often only seen from the age of 12--16 weeks onwards \[[@R31]\]. The pathogen is infrequently detected in nasal samples \[[@R31]\]. The factors allowing *A. pleuropneumoniae* to spread to and colonize lung tissue in pigs that carry the pathogen in their tonsils are not well-known. Risk factors such as stress, crowding and the moving and mixing of pigs, as well as adverse climatic conditions may be involved and contribute to the development and spread of the disease, thus affecting the rate of morbidity and mortality \[[@R85]\]. Concurrent or previous infections with other respiratory pathogens such as *Mycoplasma hyopneumoniae* \[[@R28], [@R77], [@R123]\] and Aujeszky's disease virus \[[@R100]\] can exacerbate the symptoms of pleuropneumonia. However, this was not observed with an experimental PRRSV infection \[[@R91]\].

The pathogenesis of porcine contagious pleuropneumonia is complex, involving different virulence factors of the bacterium. This article aims to present an overview of the virulence factors of *A. pleuropneumoniae* that enable the pathogen to colonize the upper and lower respiratory tract, to persist there and to induce lesions.

2.. INTERACTIONS OF *A. PLEUROPNEUMONIAE* WITH THE LOWER RESPIRATORY TRACT {#S2}
==========================================================================

The lower respiratory tract is the site where *A. pleuropneumoniae* causes tissue damage leading to clinical disease and mortality. In general, the agent enters the lungs after inhalation as an aerosol. It colonises this tissue by binding to mucus, proteins and host cells, allowing multiplication and production of substances resulting in severe damage at these sites.

2.1.. Virulence factors involved in adhesion {#S3}
--------------------------------------------

The bacteria bind preferentially to mucus, proteins and cells of the lower respiratory tract. The latter include ciliated cells of the terminal bronchioli and alveolar epithelial cells \[[@R44]\]. Several virulence factors may play a role in this adhesion phenomenon. In Table I, an overview is given of these factors and the corresponding genes.Table I.Virulence factors with confirmed or putative involvement in adhesion of *A. pleuropneumoniae* to the lower respiratory tract and the corresponding genes.(Putative) virulence factorGeneReferenceType IV fimbriae (structural subunit, 3 biogenesis components)*apfABCD*\[[@R18], [@R19], [@R44], [@R108], [@R114], [@R116], [@R125]\]Lipopolysaccharide biosynthesis*galU, rmlC, rfbN, rfbP, rfbU, rfaE*\[[@R1], [@R13], [@R14], [@R89], [@R90], [@R92], [@R93], [@R97]\]Putative adhesin (YadA outer membrane protein homologue)NA*\**\[[@R33]\]55 kDa outer membrane proteinNA\[[@R116]\]60 kDa outer membrane proteinNA\[[@R46]\]Putative adhesin (OmpA outer membrane protein homologue)*pomA*\[[@R8], [@R53]\]Fibronectin binding outer membrane protein*comE1*\[[@R80]\]Biofilm formation*pgaA, pgaC, tadF, apfB*\[[@R5], [@R27], [@R62], [@R68]--[@R70], [@R75]\]Tight adherence protein (possible involved in biofilm formation)*tadC, tadD*\[[@R5], [@R70]\]Histone-like nucleoid structuring protein (regulator of biofilm formation)*hns*\[[@R38]\]Autotransporter serine protease (involved in biofilm formation)*aasP*\[[@R3], [@R111]\]Putative autotransporter adhesin*hsf*\[[@R5], [@R8]\]Putative fimbria-like protein (possibly involved in microcolony formation)*flpD*\[[@R8]\]Putative fibronectin binding*tufA*\[[@R8]\]\* Information not available.

Fimbriae are known to be involved in the adherence of several pathogens. Type 4 fimbriae have been demonstrated on *A. pleuropneumoniae* \[[@R44], [@R114], [@R116]\], fimbrial subunits have been purified [@R125] and the type 4 fimbrial structural gene (*apfA*) has been cloned and characterized \[[@R108]\]. Boekema et al. \[[@R18], [@R19]\] demonstrated that the production of type 4 fimbriae is induced by contact with epithelial cells in vitro and during lung infection in vivo, thus suggesting their possible role in adhesion.

Several studies have demonstrated the role of lipopolysaccharides in adhesion to tracheal mucus and porcine tracheal rings maintained in culture, as well as to frozen tracheal and lung sections \[[@R13], [@R14], [@R89], [@R90]\]. Glycosphingolipids were identified as receptors in respiratory epithelial cells \[[@R1]\]. Although the involvement of lipopolysaccharides in adherence has been questioned \[[@R97]\], and the adherence of *A. pleuropneumoniae* to lung epithelial cells has been found to be lipopolysaccharide-independent \[[@R18]\], a study using mutant strains with altered lipopolysaccharide structures confirmed their role in adhesion \[[@R93]\]. The oligosaccharide core of lipopolysaccharides seems to play a role in this phenomenon. Knocking out the *rfaE* gene, which is involved in biosynthesis of lipopolysaccharides, resulted in a mutant strain that was no longer able to adhere \[[@R92]\].

Many outer membrane proteins have been identified in *A. pleuropneumoniae* \[[@R33]\]. Proteomic analysis demonstrated an outer membrane protein with similarity to YadA adhesin, which is involved in attachment and invasion of *Yersinia* \[[@R33]\]. An apparently unique outer membrane protein with a molecular weight of 55 kDa was expressed in bacteria exhibiting a high degree of adhesion to alveolar epithelial cells \[[@R116]\]. The exact role of these proteins in adhesion, however, has not yet been elucidated. An outer membrane protein of 60 kDa was found to be involved in adhesion to swine-lung collagen \[[@R46]\], and a small protein, comE1, was demonstrated to bind fibronectin \[[@R80]\]. A gene encoding a putative adhesin (*pomA*) was up-regulated in *A. pleuropneumoniae* recovered from necrotic lung tissue \[[@R8]\] and identified as important in virulence using signature-tagged mutagenesis \[[@R53]\].

Capsular polysaccharides are probably not involved in adherence, but rather mask, at least in part, the adhesive functions \[[@R98], [@R116]\]. In fact, capsular polysaccharide-associated genes are down-regulated during in vitro adhesion of *A. pleuropneumoniae* \[[@R5]\].

In vivo colonization of host tissues by bacteria is often mediated by biofilm formation. Biofilms are surface-associated colonies of bacteria embedded in an extracellular polymeric substance that enables autoaggregation and attachment to the underlying surface. Production of biofilms has been described in many *A. pleuropneumoniae* serotypes and is believed to play a role in colonization \[[@R68]--[@R70]\]. Izano et al. \[[@R62]\] identified poly-*N*-acetylglucosamine (PGA) as the major biofilm adhesin in *A. pleuropneumoniae.* Buettner et al. \[[@R27]\] demonstrated that a mutant strain deficient in biofilm formation was less virulent. The importance of a histone-like protein H-NS in biofilm formation and virulence of *A. pleuropneumoniae* has been demonstrated by Dalai et al. \[[@R38]\]. Genes involved in biofilm formation were up-regulated in vitro in a *malT* (positive transcriptional regulator of the maltose regulon) mutant strain, mimicking a stringent gene expression response during nutrient deprivation \[[@R75]\]. This up-regulation was also observed after contact of *A. pleuropneumoniae* with porcine lung epithelial cells \[[@R5]\]. The role of biofilm formation in colonization needs further examination.

An *A. pleuropneumoniae aasP* autotransporter serine protease-mutant strain showed decreased adhesion to abiotic surfaces, but still retained its full virulence, thus indicating that AasP is not necessary for full pathogenicity \[[@R111]\]. Since autotransporters can be involved in adhesin processing, the function of AasP could be to "fine-tune" the adhesion mechanisms. Until now, AasP has been demonstrated to be involved in cleavage and release of fragments of OmlA from the cell surface \[[@R3]\]. A putative autotransporter adhesin, similar to *Haemophilus* surface fibrils (hsf), was up-regulated in vitro after contact of *A. pleuropneumoniae* with porcine tracheal and lung cell lines \[[@R5]\] and in vivo in porcine necrotic lung tissue \[[@R8]\]. In *Haemophilus influenzae* serotype b, this is considered to be the major nonpilus adhesin and it was found to be associated with adherence to human epithelial cells. Whether this protein in *A. pleuropneumoniae* plays a similar role, still needs to be elucidated.

Genes homologous to those playing a role in adhesion in other bacteria, such as *flpD* and *tufA,* have been demonstrated in *A. pleuropneumoniae* \[[@R8]\]. Their possible role in pathogenesis of porcine pleuropneumonia needs further investigation.

*A. pleuropneumoniae* is able to adhere to porcine surfactant proteins B and C in vitro, but the factors involved need to be elucidated (unpublished results). Nevertheless, this association might be the first step in colonization of alveoli, followed by adhesion to the plasma membrane of alveolar epithelial cells.

In conclusion, most probably several mechanisms and antigens are involved in the adhesion of *A. pleuropneumoniae* to the lower respiratory tract. A multiple-step binding process to epithelial cells has been proposed: *A. pleuropneumoniae* might first use low-affinity binding between the O-antigen of its cell-wall lipopolysaccharides and phospholipids or short glycolipids on the host cell. Thereafter it might rely on the core oligosaccharide of its lipopolysaccharides and/or bacterial surface proteins (55 kDa outer membrane protein, type 4 fimbriae) to interact more avidly with other host cell receptors \[[@R65]\].

2.2.. Virulence factors involved in the acquisition of essential nutrients {#S4}
--------------------------------------------------------------------------

Confirmed or putative virulence factors involved in acquisition of nutrients and their corresponding genes are summarized in Table II.Table II.Confirmed or putative virulence factors of *A. pleuropneumoniae* involved in acquisition of essential nutrients and their corresponding genes.(Putative) functionGeneReferenceIron acquisition TonB1 cluster*tonB1-exbB1-exbD1-tpbB-tbpA*\[[@R5], [@R6], [@R8], [@R37], [@R40], [@R54]--[@R56], [@R88], [@R96], [@R112], [@R121]\]Iron acquisition TonB2 cluster*exbB2-exbD2-tonB2*\[[@R12], [@R40]\]Ferric hydroxamate uptake*fhuA, fhuB, fhuC, fhuD*\[[@R41], [@R70], [@R78], [@R79], [@R103]\]Hemoglobin-binding protein A precursor*hgbA*\[[@R4], [@R5], [@R15], [@R40], [@R103], [@R107]\]Putative nickel and cobalt periplasmic permease system*cbiKLMQO*\[[@R5], [@R22]\]Maltose regulon*malEFG, malK-lamB-malM, malT, malPQ*\[[@R39], [@R75], [@R76]\]Double stranded DNA binding*comE1*\[[@R80]\]ferric transporter*afuB, afuC*\[[@R70], [@R75]\]Putative arginine/ornithine antiporter*arcD*\[[@R70]\]Arginine transport system permease protein*artQ*\[[@R40]\]Branched-chain amino acid transport system carrier protein*brnQ*\[[@R75], [@R76]\]Putative ferric enterobactin transporter binding protein*fetB2*\[[@R40]\]Iron-regulated outer membrane protein B*frpB*\[[@R75], [@R76]\]Glycerol uptake facilitator and transporter*glpF, glpT*\[[@R5], [@R40], [@R70], [@R75], [@R76]\]D-ribose binding periplasmic and transport protein*rbsB, rbsD*\[[@R40], [@R75], [@R76]\]Peptide transport system permease protein*sapC*\[[@R40]\]Serine transporter*sdaC*\[[@R75], [@R76]\]Thiamine transport ATP-binding protein*thiQ*\[[@R70]\]Colicin transport proteins*tolQ, tolR*\[[@R5], [@R76]\]Urea transport*utp*\[[@R22]\]Iron (chelated) ABC transporter, periplasmic binding protein*yfeA, yfeB, yfeC, yfeD*\[[@R5], [@R40], [@R75]\], \[[@R105]\]

In the lower respiratory tract, there is a limited supply of essential nutrients for the growth of bacteria. However, *A. pleuropneumoniae* has developed a number of features to overcome this impediment. For example, the pathogen can induce lysis of several cells, resulting in the release of nutrients into the environment. Lipopolysaccharides and secreted exotoxins (see below) may both be involved in this phenomenon.

Iron can be acquired by means of transferrin binding proteins \[[@R6], [@R8], [@R12], [@R37], [@R54]--[@R56], [@R88], [@R96], [@R112], [@R121]\], siderophore receptors such as ferrichrome receptors \[[@R41], [@R78], [@R79], [@R103]\], and the binding of porcine hemoglobin by both lipopolysaccharides and outer membrane proteins \[[@R4], [@R15], [@R103], [@R107]\]. Fatty acids of the lipid A of lipopolysaccharides were shown to bind porcine hemoglobin. Lipid A is normally anchored in the outer membrane. However, during formation of outer membrane blebs, this hydrophobic moiety is better exposed, allowing binding of hemoglobin \[[@R15]\]. During in vitro growth of *A. pleuropneumoniae* under iron restriction, several genes with confirmed or putative involvement in iron acquisition were up-regulated \[[@R40]\].

The mechanism for the uptake of nickel and cobalt is not known yet, although an operon for its transportation (*cbiKLMQO*) has been demonstrated \[[@R22]\].

An outer membrane protein of 42 kDa may be involved in the uptake of maltose \[[@R39]\]. The genes involved in maltose regulation were demonstrated to be up-regulated in *A. pleuropneumoniae* exposed to bronchoalveolar lavage fluid \[[@R76]\]. Furthermore, a *malT* mutant strain exposed to bronchoalveolar fluid, expressed a gene profile resembling the stringent response during nutrient deprivation: up-regulation of genes involved in amino acid and nucleotide biosynthesis, biofilm formation, DNA transformation, and the stress response \[[@R75]\].

It has been demonstrated that some bacteria can use nucleic acids as nutrients \[[@R49]\]. In *A. pleuropneumoniae,* a small protein, Com E1, is able to bind double stranded DNA and might be involved in this alternative pathway of nutrient metabolism \[[@R80]\].

In different experimental set-ups, similar genes as described above and several other genes encoding putative factors involved in nutrient uptake have been demonstrated (Tab. II) \[[@R5], [@R22], [@R40], [@R70], [@R75], [@R76], [@R105]\].

2.3.. Virulence factors involved in the induction of lesions {#S5}
------------------------------------------------------------

The first, and probably most important, are the pore-forming exotoxins ApxI, ApxII and ApxIII \[[@R52]\] (Tab. III). All virulent *A. pleuropneumoniae* strains express 1 or 2 of these toxins. The genes involved in the production and secretion of Apx toxins have been well-characterized \[[@R52]\]. The secretion of Apx toxins results in lysis of alveolar epithelial cells, endothelial cells, red blood cells, neutrophils and macrophages \[[@R42], [@R43], [@R50], [@R51], [@R102], [@R115]\]. The adhesion of *A. pleuropneumoniae* to cells of the host may allow bacteria to release their toxins directly to the surface of the host cell membrane, resulting in the destruction of these cells, even in the presence of Apx toxin-neutralizing antibodies \[[@R59]\]. A fourth toxin (ApxIV), which has been demonstrated in all *A. pleuropneumoniae* strains \[[@R101]\], is essential for full virulence \[[@R74]\]. It is only expressed under in vivo conditions \[[@R32], [@R101]\]. The *apxIVA* gene was up-regulated during contact with bronchoalveolar fluid in vitro \[[@R75], [@R76]\] and expressed in necrotic porcine lung tissue in vivo \[[@R8]\]. Its exact role in pathogenesis, however, still needs to be elucidated.Table III.Virulence factors with confirmed or putative involvement in the induction of lesions by *A. pleuropneumoniae* and the corresponding genes.(Putative) virulence factorGeneFunctionReferencePore forming RTX toxin I (activator, structural unit, secretion proteins)*apxICABD*Strongly haemolytic; strongly cytotoxic for alveolar macrophages and neutrophils\[[@R42], [@R50]--[@R52], [@R59], [@R115]\]Pore forming RTX toxin II (activator, structural unit)*apxIICA*Weakly haemolytic; moderately cytotoxic for alveolar macrophages and neutrophils\[[@R42], [@R43], [@R50]--[@R52], [@R59], [@R102], [@R115]\]Pore forming RTX toxin III (activator, structural unit, secretion proteins)*apxIIICABD*Non-haemolytic, strongly cytotoxic for alveolar macrophages and neutrophils\[[@R42], [@R43], [@R50]--[@R52], [@R59], [@R115]\]Putative pore forming RTX toxin IV*apxIVA*Uncertain, required for full virulence\[[@R8], [@R32], [@R74]--[@R76], [@R101]\]Lipopolysaccharide biosynthesis*galU, rmlC, rfbN, rfbP, rfbU, rfaE*Enhanced effect of Apx toxins on phagocytes, activation of production of inflammatory cytokines, induction of necrosis in porcine lung epithelial cells\[[@R5], [@R47], [@R48], [@R93], [@R94]\]ProteasesNA*\**Degradation of porcine gelatin, actin, hemoglobin\[[@R81]--[@R83]\]\* Information not available.

Lipopolysaccharides also have the potential to cause damage to host cells. They are a major constituent of the outer membrane of Gram-negative bacteria. The lipopolysaccharides of *A. pleuropneumoniae* may contribute to the formation of lesions. They enhance the effects of Apx toxins on phagocytes, activate the production of inflammatory cytokines \[[@R47], [@R48], [@R93]\] and induce necrosis in porcine lung epithelial cell lines via binding to Toll-like receptors \[[@R5]\]. Direct binding of lipopolysaccharide outer core (GalNAc-Gal II-Gal I) to ApxI and II toxins might explain the enhanced cytotoxicity \[[@R94]\].

Other factors that may play a role in tissue damage are the different proteases secreted by *A. pleuropneumoniae*, which degrade porcine gelatine, actin and hemoglobin \[[@R81]--[@R83]\].

2.4.. Virulence factors involved in avoiding the host's defense mechanisms {#S6}
--------------------------------------------------------------------------

The effectiveness of the host's defense against pulmonary bacterial infections depends on the rapid clearance of the microorganisms from the respiratory tract \[[@R23]\]. Besides nonspecific factors such as the ciliary beat, the cough reflex and mucus clearance, the innate pulmonary immunity is composed of a cellular portion (airway and alveolar epithelial cells, resident and recruited leukocytes) and a humoral component (antimicrobial products secreted in the epithelial lining fluid) \[[@R124]\]. *A. pleuropneumoniae,* however, possesses several properties that enable it to avoid the host's immune system (Tab. IV).Table IV.Confirmed or putative virulence factors of *A. pleuropneumoniae* involved in avoiding the host's defense mechanism and the corresponding genes.(Putative) virulence factorGeneFunctionReferenceProteasesNA*\**Degradation of porcine IgA and IgG\[[@R81], [@R82]\]Apx toxinssee Table IIICytolysis of neutrophils and macrophages, apoptosis of alveolar macrophages, impairment of macrophage chemotactic and phagocytotic function, intracellular survival\[[@R29], [@R34], [@R36], [@R42], [@R43], [@R110]\]Urease*ureABC, ureDEFG*Intracellular survival, impairment of macrophage function, toxic for macrophages\[[@R20], [@R21]\]Carbohydrates in capsule and lipopolysaccharidesNAIntracellular survival\[[@R16]\]Heat-shock protein*dnaK*Intracellular survival\[[@R53]\]Cu-Zn superoxide dismutase*sodC*Intracellular survival\[[@R71], [@R104]\]Capsular polysaccharide*cpxDCBA*Antiphagocytic, serum resistance\[[@R8], [@R11], [@R61], [@R66], [@R75], [@R97]--[@R99], [@R113], [@R118]--[@R120]\]Regulator of the maltose regulon*malT*Serum resistance\[[@R75]\]\* Information not available.

*A. pleuropneumoniae* can survive a 30 min exposure to bronchoalveolar lavage fluid while 70% of *Escherichia coli* cells were killed \[[@R76]\]. Genes involved in cell envelope, DNA, and protein biosynthesis as well as those playing a role in the bacterium's energy metabolism were most frequently up-regulated. Genes encoding proteins for co-factor biosynthesis, toxin production and secretion and trafficking of ions and biomolecules were also up-regulated while genes encoding proteins involved in protein folding and stabilization, nucleotide biosynthesis, and mobile elements were down-regulated \[[@R75], [@R76]\].

The pathogen secretes proteases that degrade porcine IgA and IgG \[[@R81], [@R82]\]. It is not known whether these proteases impair the host's defense against bacterial adhesion, toxins or in vivo opsonization.

ApxI, II and III toxins have lethal effects on neutrophils and macrophages \[[@R36], [@R42], [@R43]\] and may thus also play a role in impairing the host's defenses. Chien et al. \[[@R29]\] demonstrated that ApxI induces apoptosis of pulmonary alveolar macrophages. At sublytic dose, the toxins impair macrophage chemotactic and phagocytic functions \[[@R110]\].

An *A. pleuropneumoniae* serotype 2 mutant strain, deficient in production of ApxII and ApxIII, was still capable of damaging porcine alveolar macrophages in vitro \[[@R36]\]. Therefore, other cytotoxic factors could be involved, such as ammonia. Indeed, urease activity is present in all *A. pleuropneumoniae* serotypes and ammonia may act synergistically with Apx toxins. This may contribute to cytotoxicity, as well as to impaired macrophage function \[[@R20], [@R21]\].

After phagocytosis, *A. pleuropneumoniae* can survive for up to 90 min in macrophages \[[@R34]\]. Several factors may contribute to this intracellular survival, such as high molecular-weight surface carbohydrates present in capsule and lipopolysaccharides \[[@R16]\], secretion of Apx toxins \[[@R34]\], heat-shock proteins \[[@R53]\], ammonia \[[@R21]\] and copper-zinc superoxide dismutase \[[@R71], [@R104]\].

Capsular polysaccharides and/or lipopolysaccharides of *A. pleuropneumoniae* exert antiphagocytic properties \[[@R61], [@R97]--[@R99], [@R113], [@R118], [@R120]\]. Furthermore, Ward et al. \[[@R118]\] demonstrated that capsulated (*A. pleuropneumoniae* serotype 5a) strains were resistant to complement-mediated killing, whereas non-capsulated strains were killed. However, this may be serotype or strain dependent since a serotype 1 capsule mutant still was resistant \[[@R98]\]. A *malT* mutant strain was not able to survive following incubation with porcine serum. This may be due to changes in its cell surface polysaccharide composition \[[@R75]\]. Anyway, virulence of an *A. pleuropneumoniae* strain is influenced by the amount and type of capsular polysaccharides as well as by its mechanism of expression \[[@R11]\]. The genetic organization of the capsule biosynthesis region of several *A. pleuropneumoniae* serotypes has been described \[[@R66], [@R119], [@R120]\]. Several of these genes were up-regulated in necrotic lung tissue \[[@R8]\] and during contact with bronchoalvealar lavage fluid \[[@R75]\].

Finally, biofilm formation may also increase resistance to the host's immune system by interfering with the macrophage phagocytic activity so as to keep the antibodies from reaching the surface of the bacterial cells and thus decreasing these cells' sensitivity to killing by polymorphonuclear leukocytes \[[@R25], [@R45]\]. However, this still needs to be demonstrated in *A. pleuropneumoniae*.

2.5.. Virulence factors involved in persistence {#S7}
-----------------------------------------------

A summary of virulence factors possibly involved in persistence and the corresponding genes is presented in Table V.Table V.Virulence factors of *A. pleuropneumoniae* with putative involvement in persistence in the upper respiratory tract and the corresponding genes.(Putative) virulence factorGeneReferenceAspartate ammonia-lyase*aspA*\[[@R64]\]Global anaerobic regulator*hlyX*\[[@R7], [@R9], [@R10]\]Dimethylsulfoxide reductase*dmsA, dmsB, dmsC*\[[@R7], [@R8]\]Hemoglobin binding protein*hgbA*\[[@R8]\]Capsular polysaccharide export*cpxB, cpxC, cpx D*\[[@R10], [@R105]\]Lipopolysaccharide biosynthesis*galU, rmlC, rfbN, rfbP, rfbU*\[[@R105]\]Autotransporter serine protease*aasP*\[[@R10]\]Stress protein*dnaK*\[[@R10]\]Branched-chain amino acid biosynthesis*IlvI*\[[@R109]\]Aerobic respiration control protein*acrA*\[[@R26]\]

*A. pleuropneumoniae* may persist during prolonged periods of time in necrotic lung tissue \[[@R8]\]. At this site, oxygen availability is low. In such conditions, *A. pleuropneumoniae* expresses a global regulatory gene (*hlyX*) that activates production of several enzymes such as dimethyl sulfoxide reductase and aspartate ammonia lyase, which enable anaerobic respiration of the bacterium \[[@R7], [@R9], [@R10], [@R64]\]. Expression of genes encoding hemoglobin-binding proteins and dimethylsulfoxide reductase is also stimulated \[[@R7], [@R8]\].

Sheehan et al. \[[@R105]\] demonstrated that several genes are required for the survival of *A. pleuropneumoniae* in its porcine host, including the genes involved in biosynthesis of cell surface structures, energy metabolism, nutrient uptake and stress response. In addition, Baltes et al. \[[@R10]\] demonstrated the up-regulation of different genes involved in nutrient transport, stress response, energy metabolism and the synthesis of nucleic acids or cellular components in the chronic stage of the disease.

Flagella and motility in *A. pleuropneumoniae* have been demonstrated, but their role in pathogenesis and survival in the host has not yet been elucidated \[[@R84]\].

In lung fluid, essential branched-chain amino acids, such as isoleucine, leucine, and valine are limited. Subashchandrabose et al. \[[@R109]\] demonstrated that a gene encoding an enzyme (acetohydroxyacid synthase) required for branched-chain amino acid biosynthesis was expressed in *A. pleuropneumoniae* in vivo, and that this was necessary for survival and full virulence.

In a recent study, Buettner et al. \[[@R26]\] demonstrated the importance of ArcA (a global cytosolic response regulator facilitating metabolic adaptation to anaerobicity and changing redox potential) in biofilm formation and autoaggregation, and hypothetized that ArcA plays an essential role in respiratory tract persistence of *A. pleuropneumoniae.* Biofilm formation does not only allow colonization. Bacteria in a biofilm also often exhibit increased resistance to antimicrobial agents, making it difficult to eradicate \[[@R68]\]. However, no genetic data are yet available confirming this hypothesis.

ComE1 has been shown to play a major role in natural transformation of some *A. pleuropneumoniae* strains, which could allow adaptation of the bacterium and persistence in the host \[[@R24], [@R80]\].

Taken together, all this evidence indicates that the pathogen has a capacity to adapt to different environmental conditions enabling long-time survival in the host.

3.. INTERACTIONS OF *A. PLEUROPNEUMONIAE* WITH THE UPPER RESPIRATORY TRACT AND TONSILS {#S8}
======================================================================================

*A. pleuropneumoniae* may colonize the tonsils and, albeit to a lesser extent, the nasal mucosa in the presence or absence of lung colonization \[[@R63], [@R86], [@R106]\]. Indeed, in some subclinical infections, the bacterium does not enter the lungs but persists in the tonsils, thus resulting in symptom-free carriers \[[@R31], [@R58], [@R67], [@R106], [@R117], [@R122]\]. In such animals, antibodies against *A. pleuropneumoniae* are usually not detected \[[@R31], [@R73], [@R106]\].

Although healthy animals may carry *A. pleuropneumoniae* in their nose, information on the mechanisms by which the bacterium resides in this organ is lacking.

Adhesion of *A. pleuropneumoniae* to tracheal crude mucus has been well documented and lipopolysaccharides were found to be involved \[[@R14]\]. Since the epithelium of tonsils is also covered by a mucus layer, such interaction may constitute a first step in colonization. However, mucus (and attached bacteria) is continuously being cleared, and therefore bacteria need other mechanisms to persist. Such a mechanism could involve a specific binding of bacteria to epithelial cells. Indeed, *A. pleuropneumoniae* adheres to surface and crypt tonsillar epithelial cells. This was presumed to be a specific interaction since the bacteria were closely associated with microprojections of epithelial cells \[[@R30]\]. A similar two-step mechanism has been described in the pathogenesis of *Streptococcus pyogenes* pharyngotonsillitis in humans \[[@R72]\]. Adherent biofilms have been shown to be associated with chronic tonsillitis in children \[[@R2]\]. Whether biofilm formation contributes to the colonization of *A. pleuropneumoniae* in porcine tonsils, however, still needs to be elucidated.

There is speculation that tonsillar crypts are the niche in which *A. pleuropneumoniae* may persist \[[@R30]\]. The mechanism by which this happens is not known, but since bacteria are localized in the deeper parts of the crypts and tonsils are covered by mucus, oxygen availability is probably low at these sites. Therefore, similar mechanisms as have been proposed for persistence in necrotic lung tissue may play a role \[[@R7], [@R64]\]. For instance, it was demonstrated that a *hlyX* (gene involved in anaerobic respiration) mutant is unable to persist in tonsils \[[@R9]\]. In addition, maltodextrin carbohydrate metabolism also might play a role in tonsillar persistence, since all serotypes of *A. pleuropneumoniae* possess the maltose-regulon genes and maltodextrins can be found in the oropharynx \[[@R75]\].

In natural *A. pleuropneumoniae* infections, the tonsils and nasal mucosa are not routinely examined for the presences of lesions, and information on this subject is therefore lacking. However, experimental inoculation of tonsils in gnotobiotic piglets resulted in vacuolization, localized disruption and necrosis of the superficial epithelium with subsequent hyperemia and neutrophilic inflammation \[[@R30]\]. The factors involved in these findings were not examined. Since the events are very similar to those inducing lung lesions, it is tentative to speculate that similar virulence factors may play a role.

4.. CONCLUSIONS {#S9}
===============

The virulence factors and their corresponding genes involved in lung colonization and induction of lung lesions by *A. pleuropneumoniae* have been thoroughly studied and some have been well characterized. This information has been used to design new vaccines that induce partial protection against the disease \[[@R60], [@R95]\]. *A. pleuropneumoniae* has the capacity to persist in its host during prolonged periods of time, and this factor plays a role in the spread of the infection. In addition to persistence in lung lesions, the colonization of the upper respiratory tract and of the tonsils, in particular, is important for long-term persistent asymptomatic infection. Information on virulence factors involved in tonsillar and nasal cavity colonization and persistence is scarce.

The availability of full genomes of *A. pleuropneumoniae* should allow new approaches to further clarify the role of selective genes in the pathogenesis of porcine pleuropneumonia and persistence of the micro-organism in its host. It may also help to elucidate cellular mechanisms and pathways involved in these processes.
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